Michel Faupel

Chief Operating Officer & Vice President at Rhenovia Pharma SAS

Michel Faupel

Michel Faupel

Chief Operating Officer & Vice President at Rhenovia Pharma SAS

Biography

Mr. Michel Faupel is Vice President at Rhenovia Pharma SAS. Mr. Faupel was previously employed as Chemist by Novartis Institutes for Biomedical Research, Inc.

Overview
Career Highlights

Rhenovia Pharma SAS

RelSci Relationships

272

Relationships
RelSci Relationships are individuals Michel Faupel likely has professional access to. A relationship does not necessarily indicate a personal connection.

Professor at University of Southern California

Relationship likelihood: Strong

Co-Founder at Rhenovia Pharma SAS

Relationship likelihood: Strong

Associate Dean at Western University of Health Sciences - College of Osteopathic Medicine of the Pacific

Relationship likelihood: Strong

Executive Director of Development at Western University of Health Sciences

Relationship likelihood: Strong

Chief Financial Officer & Treasurer at Western University of Health Sciences

Relationship likelihood: Strong

Dean of Comp at Western University of Health Sciences

Relationship likelihood: Strong

Provost & Chief Operating Officer at Western University of Health Sciences

Relationship likelihood: Strong

Former Provost & Chief Operating Officer at Western University of Health Sciences

Relationship likelihood: Strong

Dean, College of Podiatnc MEd at Western University of Health Sciences

Relationship likelihood: Strong

Program Chair at Western University of Health Sciences

Relationship likelihood: Strong

Paths to Michel Faupel
Potential Connections via
Relationship Science
You
Michel Faupel
Chief Operating Officer & Vice President at Rhenovia Pharma SAS
Career History
Chief Operating Officer & Vice President
2007 - Current

Rhenovia Pharma SAS provides pharmaceutical research services. It offers solutions in the field of Alzheimer's and other diseases of the nervous system. The firm’s product include Directorug discovery optimization service, first operational service and consulting service. The company was founded by Serge Bischoff, Michel Baudry, Michel Faupel, Jacques Baudry and Jan Kremers in May 2007 and is headquartered in Mulhouse, France.

Professor of Biomedical Sciences & Dean of the Graduate College of Biomedical Sciences
Tenure Unconfirmed

TO PRODUCE, IN A HUMANISTIC TRADITION, HEALTH CARE PROFESSIONALS AND BIOMEDICAL KNOWLEDGE THAT WILL ENHANCE AND EXTEND THE QUALITY OF LIFE IN OUR COMMUNITIES.

Chemist
Prior

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Investments
Details Hidden

Rhenovia Pharma SAS provides pharmaceutical research services. It offers solutions in the field of Alzheimer's and other diseases of the nervous system. The firm’s product include Directorug discovery optimization service, first operational service and consulting service. The company was founded by Serge Bischoff, Michel Baudry, Michel Faupel, Jacques Baudry and Jan Kremers in May 2007 and is headquartered in Mulhouse, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michel Faupel. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michel Faupel's profile does not indicate a business or promotional relationship of any kind between RelSci and Michel Faupel.